Uncategorized

OvuSense Manufacturer Fertility Focus Announces the Launch of OvuFirst, a New Skin-Worn Sensor for Ovulation Tracking

Fertility Focus, the manufacturers of the OvuCore and OvuSense Pro family of fertility monitoring solutions, today announces the launch of OvuFirst, a unique patented sensor designed to measure skin temperature, providing women with an understanding of when to try and conceive naturally, and enabling them to determine what issues they may have trying to conceive. OvuFirst is targeted at women who wish…

Auransa and POLARISqb Enter Research Collaboration to Find Treatments for Neglected Women’s Diseases Like Endometriosis and PCOS

Auransa, an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women. The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research.  Auransa…

Cambridge Femtech Society: An Interview with Emily Otterbeck & Lesley Farrah Dorwling-Carter, Founders of the First Femtech Society at a European University

Is student engagement in the femtech community crucial in raising awareness of the field among researchers, innovators and future entrepreneurs? Lesley Farrah Dorwling-Carter and Emily Otterbeck, two students currently enrolled in Cambridge University’s MPhil in Bioscience Enterprise Program, certainly think so! And this belief has recently led them to launching the Cambridge Femtech Society, the first official society dedicated to women’s health…

Event: Investing and Fundraising in Healthtech and Femtech (Women of Wearables)

On June 17 Women of Wearables (WoW) are running an all-day conference about investing and fundraising in healthtech and femtech targeted at with startups, investors and experts. Investing and Fundraising in HealthTech and FemTech is a global virtual conference answering all your questions about fundraising and investing in this space. It’s a global meetup of investors and founders sharing their insights, knowledge,…

Women’s Health Company Tia Opens Its Third Location in Phoenix

Women’s health startup Tia today announced the opening of its third location in Phoenix. Just months ago the company opened its second location in Los Angeles and announced a partnership with Common Spirit. Tia is known for championing the concept of “Whole Person Health” and aims to recreate a healthcare system that was designed for specialties, body parts, and treating sickness. The company announced…

What’s New in Femtech This Week? (June 3, 2021)

Highlights Madrid-based IVF startup Overture Life raises a $15M Series B. Israeli femtech company Ark Surgical raises $2.1M for its LapBox tissue containment system for laparoscopic GYN Surgery. Proov announces a new patented test method for assessing ovarian quality. Emme Expands Its Birth Control Offering and Launches EmmeRx, a New Prescription Delivery and Telemedicine Service. Psychedelic Biotech Eastra Health launches with plans to address menopause and PMS. CCRM Fertility launches “The F-Word Collection” to…

SCYNEXIS Receives FDA Approval for BREXAFEMME, the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

Biotech company SCYNEXIS has announced FDA (U.S. Food and Drug Administration) approval of BREXAFEMME (ibrexafungerp tablets) for oral use in patients with vulvovaginal candidiasis (VVC), also known as vaginal yeast infection. BREXAFEMME is the first approved drug in a novel antifungal class in more than 20 years and was approved based on positive results from two Phase 3 studies in which oral ibrexafungerp demonstrated…

Ark Surgical Raises $2.1M for its LapBox Tissue Containment System for Laparoscopic GYN Surgery

Israeli femtech startup Ark Surgical has secured $2.1 million in funding for its LapBox containment system for secure removal of large internal organs during laparoscopic GYN surgery. The financing was raised from investors of the Together equity crowdfunding platform alongside the Israeli Innovation Authority and NGT. Ark Surgical has completed the first-in-human (FIH) study demonstrating the safety and effectiveness of the LapBox. Approximately 600,000 hysterectomies…